The Graft Versus Host Disease (GVHD) market has seen steady growth due to advancements in stem cell transplantation, an increasing number of hematopoietic stem cell transplantations (HSCT), and growing awareness of the condition's complex immunological mechanisms. GVHD is a common complication that occurs when donor cells attack the recipient's tissues after a bone marrow or stem cell...